These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6109178)

  • 1. Arginine vasopressin and choline acetyltransferase in brains of patients with Alzheimer type senile dementia.
    Rossor MN; Iversen LL; Mountjoy CQ; Roth M; Hawthorn J; Ang VY; Jenkins JS
    Lancet; 1980 Dec 20-27; 2(8208-8209):1367-8. PubMed ID: 6109178
    [No Abstract]   [Full Text] [Related]  

  • 2. Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer type.
    Rossor MN; Rehfeld JF; Emson PC; Mountjoy CQ; Roth M; Iversen LL
    Life Sci; 1981 Jul; 29(4):405-10. PubMed ID: 7278494
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.
    Rossor MN; Emson PC; Mountjoy CQ; Roth M; Iversen LL
    Neurosci Lett; 1980 Dec; 20(3):373-7. PubMed ID: 6108540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.
    Yates CM; Simpson J; Gordon A; Maloney AF; Allison Y; Ritchie IM; Urquhart A
    Brain Res; 1983 Nov; 280(1):119-26. PubMed ID: 6228286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senile dementia and presenile dementia.
    Nakamura S
    Tohoku J Exp Med; 1990 Aug; 161 Suppl():49-60. PubMed ID: 1707190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotransmitters in dementia.
    Nakamura S; Koshimura K; Kato T; Yamao S; Iijima S; Nagata H; Miyata S; Fujiyoshi K; Okamoto K; Suga H
    Clin Ther; 1984; 7 Spec No():18-34. PubMed ID: 6152197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotransmitters of the cerebral cortex in senile dementia of Alzheimer type.
    Rossor MN; Emson PC; Mountjoy CQ; Roth M; Iversen LL
    Exp Brain Res; 1982; Suppl 5():153-7. PubMed ID: 6129994
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurotransmitter and neuropeptide systems in Alzheimer-type dementia.
    Perry EK; Perry RH
    Exp Brain Res; 1982; Suppl 5():140-5. PubMed ID: 6185355
    [No Abstract]   [Full Text] [Related]  

  • 9. An update on the neurochemistry of Alzheimer disease.
    Davies P
    Adv Neurol; 1983; 38():75-86. PubMed ID: 6137134
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemistry of Dementias.
    Bowen DM
    Proc R Soc Med; 1977 May; 70(5):351-3. PubMed ID: 141671
    [No Abstract]   [Full Text] [Related]  

  • 11. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Crystal HA; Davies P
    J Neurochem; 1982 Jun; 38(6):1781-4. PubMed ID: 6176686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia.
    Sakurada T; Alufuzoff I; Winblad B; Nordberg A
    Brain Res; 1990 Jun; 521(1-2):329-32. PubMed ID: 1698512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choline in Alzheimer's disease.
    Spillane JA; Goodhart MJ; White P; Bowen DM; Davison AN
    Lancet; 1977 Oct; 2(8042):826-7. PubMed ID: 71636
    [No Abstract]   [Full Text] [Related]  

  • 14. Acetylcholine and brain aging.
    Pepeu G
    Pharmacol Res Commun; 1988 Feb; 20(2):91-7. PubMed ID: 3289049
    [No Abstract]   [Full Text] [Related]  

  • 15. Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia.
    Arai H; Moroji T; Kosaka K
    Neurosci Lett; 1984 Nov; 52(1-2):73-8. PubMed ID: 6152043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A biochemical study of cholinergic neurons of the post-mortem brains from the patients with Alzheimer-type dementia].
    Arai H; Kosaka K; Muramoto O; Iizuka R
    Rinsho Shinkeigaku; 1984 Nov; 24(11):1128-35. PubMed ID: 6518703
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.
    Fujiyoshi K; Suga H; Okamoto K; Nakamura S; Kameyama M
    J Neurol Neurosurg Psychiatry; 1987 Jul; 50(7):929-32. PubMed ID: 3625218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choline acetyltransferase and acetylcholinesterase abnormalities in senile dementia: importance of biochemical measurements in human post-mortem brain specimens.
    Sorbi S; Antuono P; Amaducci L
    Ital J Neurol Sci; 1980 Mar; 1(2):75-83. PubMed ID: 7040296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic receptor compensation in hippocampus of Alzheimer patients.
    Nordberg A; Larsson C; Adolfsson R; Alafuzoff I; Winblad B
    J Neural Transm; 1983; 56(1):13-9. PubMed ID: 6133910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cholinergic system in old age and Alzheimer's disease.
    Perry EK
    Age Ageing; 1980 Feb; 9(1):1-8. PubMed ID: 7361631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.